Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Li Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9965-989X; OpenAlex author ID A5029440132. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Barriers and opportunities in pancreatic cancer immunotherapy. Last author DOI 10.1038/s41698-024-00681-z↗
  2. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Last author DOI 10.1038/s41467-021-27349-7↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yixin Ju · 1 shared paper, 2024 · strength 0.24
  2. Di Zhao · 1 shared paper, 2021 · strength 0.10
  3. Yalan Deng · 1 shared paper, 2021 · strength 0.10
  4. Wenjuan Yin · 1 shared paper, 2021 · strength 0.10
  5. Jun Yao · 1 shared paper, 2021 · strength 0.10
  6. Haoqiang Ying · 1 shared paper, 2021 · strength 0.10
  7. Mien‐Chie Hung · 1 shared paper, 2021 · strength 0.10
  8. Qinglei Hang · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.